- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
NIPER, Hindustan Antibiotic sign MoU for developing 3D antimicrobial face-shields
NIPER-Guwahati has also filed both an Indian design patent and provisional patent at Indian Patent Office, New Delhi on their 3D printed antimicrobial face-shields
New Delhi: National Institute of Pharmaceuticals Education and Research (NIPER)-Guwahati, a premier Institute of National Importance under the Department of Pharmaceuticals, Union Ministry of Chemicals and Fertilizers, Govt. of India is committed to providing a useful contribution cum solution in terms of developing Personal Protective Equipment's (PPEs) to avoid the fatal spread of COVID-19 transmission.
Director Dr. U S N. Murty informed that he signed MoU with the Hindustan Antibiotic Limited (HAL, a PSU under Dept. of Pharmaceuticals, Govt. of India), Pimpri, Pune for large scale industrial-grade manufacturing and commercialization of their 3D printed antimicrobial face-shields.
NIPER-Guwahati has also filed both an Indian design patent and provisional patent at Indian Patent Office, New Delhi on their 3D printed antimicrobial face-shields.
NIPER-G has designed, developed & validated 3D-printed antimicrobial face-shield to control the spread of novel coronavirus, after careful analyses of several resources for risk measurement and on how viruses spread through bare hands and other body cavities like oral, ophthalmic & olfactory, etc. (even though ear as well). Some of the salient features of their developed 3D printed antimicrobial face-shields include, highly occlusive, transparent, easy-to-design, low cost, easy to wear, antimicrobial in nature, excellent chemical stability, non-fragile and easy to clean with the existing sanitizers or any alcoholic disinfectant.
In addition to this, NIPER-G designed & developed a 3D-printed multi-layer antimicrobial face mask to control the spread of novel coronavirus. The first layer of this mask will be anti-bacterial casing, the second layer will be the sanitizing layer and reducing exposure of airborne particulates. finally, the third layer will be the medicinal layer to prevent extra microbial attacks, etc.
Finally, NIPER-G has also developed & validated a 3D-printed hands-free multi-tasking object for opening or closing of the doors, windows, drawers (both vertical & horizontal), refrigerator handle, elevator buttons, laptop/desktop keyboards, including turning on/off switch buttons. This product is very handy, user-friendly, non-fragile, and easy to clean with the existing sanitizers or any alcoholic disinfectant.
Read also: NIPERs focuses on research, 3D products to fight COVID19
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751